Derrick Sung

Derrick Sung

Director of Finance/CFO at PULMONX CORPORATION

Net worth: 220 570 $ as of 2026-07-30

53 year
Health Technology
Consumer Services
Finance

Profile

Derrick Sung is currently Director at Sensydia Corp.
since 2018, Chief Financial Officer at Aerin Medical, Inc. since 2023, and Chief Operating & Financial Officer at Pulmonx Corp.
starting in 2025.
Former positions include Director-Marketing & Business Development at Boston Scientific Corp.
from 2004 to 2008, Independent Director at Minerva Surgical, Inc. from 2022 to 2024, Chief Financial & Accounting Officer at Pulmonx Corp.
from 2019 to 2023, Executive VP-Strategy & Corporate Development at iRhythm Holdings, Inc. from 2015 to 2019, Senior Research Analyst at Sanford C.
Bernstein & Co. LLC from 2008 to 2014, Principal at Vascular Intervention, and Principal at The Boston Consulting Group, Inc. from 2000 to 2004.
Education includes undergraduate studies at Stanford University, an MBA from San Diego State University, and a doctorate from the University of California San Diego.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-14 135,319 ( 0.32% ) 220 570 $ 2026-07-30

Derrick Sung active positions

CompaniesPositionStart
PULMONX CORPORATION Director of Finance/CFO 2025-11-02
Director of Finance/CFO 2023-11-19
Director/Board Member 2018-07-31

Former positions of Derrick Sung

CompaniesPositionEnd
MINERVA SURGICAL, INC. Director/Board Member 2023-12-31
PULMONX CORPORATION Director of Finance/CFO 2023-10-09
IRHYTHM HOLDINGS, INC. Corporate Officer/Principal 2019-04-30
BOSTON SCIENTIFIC CORPORATION Sales & Marketing 2007-12-31
Corporate Officer/Principal 2003-12-31
See the detail of Derrick Sung's experience

Training of Derrick Sung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Finance

Consumer Services

Consumer Services

Vascular Intervention

Finance